| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4260a256b5f28ea7d92b4c1f5b921d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2009-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d5835f285ae6f3a465428d620267c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03fcc705f6cf849ba35a255ab0b0559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5bd94ae6f55ce42ea97757252dca9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3f44b2b0c6cbb495daa9128134377a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9db351e24f52af2d0682a5ebcb2d065 |
| publicationDate |
2011-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102056623-A |
| titleOfInvention |
immunogenic composition |
| abstract |
The present invention relates to the use of CCR4 antagonists as adjuvants, especially in immunogenic compositions comprising antigens that elicit an immune response against pathogens or tumors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103102314-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110613711-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110613711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104622874-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103102314-A |
| priorityDate |
2008-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |